Trials / Completed
CompletedNCT00153738
Phytosterol Supplementation and Cardiovascular Risk
Effectiveness of Phytosterol Supplementation on Select Indices of Cardiovascular Risk
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 72 (planned)
- Sponsor
- The Cooper Institute · Academic / Other
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
This study examined the effects of 2.6 g/d of phytosterol ingestion on LDL cholesterol metabolism. It is expected that this dose will significantly reduce LDL cholesterol after 12 weeks of supplementation.
Detailed description
This study examined the effects of 2.6 g/d of phytosterol ingestion on LDL cholesterol metabolism. It is expected that this dose will significantly reduce LDL cholesterol after 12 weeks of supplementation. The study recruited 72 men and women 20-70 years of age with mild hypercholesteremia (\>130 mg/dl LDL-C). They were assigned to 1 of 2 groups. Participants ingested the supplement or a placebo for 12 weeks, with an interim assessment at 6 weeks. Participants agreed to maintain current diet, medication, and exercise habits and to not donate blood during the trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | phytosterol |
Timeline
- Start date
- 2004-03-01
- Completion
- 2005-08-01
- First posted
- 2005-09-12
- Last updated
- 2014-03-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00153738. Inclusion in this directory is not an endorsement.